Skip to main content

Peer Review reports

From: Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021 – December 2022

Original Submission
22 May 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
24 Oct 2023 Reviewed Reviewer Report
31 Oct 2023 Reviewed Reviewer Report
6 Nov 2023 Reviewed Reviewer Report
22 Dec 2023 Author responded Author comments - Hinta Meijerink
Resubmission - Version 4
22 Dec 2023 Submitted Manuscript version 4
28 Dec 2023 Author responded Author comments - Hinta Meijerink
Resubmission - Version 5
28 Dec 2023 Submitted Manuscript version 5
10 Jan 2024 Reviewed Reviewer Report
10 Jan 2024 Reviewed Reviewer Report
26 Jan 2024 Reviewed Reviewer Report
15 Feb 2024 Author responded Author comments - Hinta Meijerink
Resubmission - Version 6
15 Feb 2024 Submitted Manuscript version 6
Publishing
4 Jul 2024 Editorially accepted
11 Jul 2024 Article published 10.1186/s12889-024-19374-0

You can find further information about peer review here.

Back to article page